- VIDEO: Practice Essential - Back to Basics in the Diagnosis and Prognosis of AML - Keith W. Pratz, MD
- FAQ - Is molecular testing currently part of the standard routine testing in the community setting for patients diagnosed with AML? - Brian Druker, MD
- VIDEO: FAQ - What is the recommended baseline cytogenetic molecular and immune profiling workup in a patient with newly diagnosed AML? - Naval Daver, MD
- FAQ - When do I suspect the diagnosis of acute myeloid leukemia? - Keith W. Pratz, MD
- FAQ - What if an aspirate cannot be obtained on my patient? - Keith W. Pratz, MD
- FAQ - What are the diagnostic requirements for acute myeloid leukemia? - Keith W. Pratz, MD
Top Picks: Accredited Activities
Top Picks: FAQS
Diagnosis and Prognosis
MediCom Worldwide, Inc. would like to recognize and thank the following companies for their educational support of Managing AML.com
- Agios Pharmaceuticals, Inc.
- Celgene Corporation
- Incyte Corporation
- Jazz Pharmaceuticals, Inc.
- Novartis Pharmaceuticals